Austrian study 'confirms' long-term immunity of recovered Covid patients

The Local
The Local - [email protected] • 20 Jun, 2021 Updated Sun 20 Jun 2021 15:57 CEST
image alt text
Free tests have played a central role in Austria's Covid-19 strategy. Could it soon change? Photo by: Alex Halada/ AFP.

A study conducted by the UniMed Innsbruck has found that people who have recovered from a coronavirus infection build long-term immunity through the development of anti-bodies. The authors say that people who have been infected will improve their immunity further through a booster jab.

The team tested 27 people who had been confirmed to have the virus at several points over a 12-month period, and all showed a robust immune response throughout that time.

"Those who have recovered are immune," study author Florian Deisenhammer told news agency APA. "We can be very, very sure that we will get rid of the problem via immunity."

He added that: "We can reassure society. The immune system works. One is immune."

"It is much easier and safer to achieve immunity through vaccination alone because it is faster and avoids possible long-term consequences of the disease," he added.

Two of the members of the study came in direct contact with people who were infected during the course of the year, but did not suffer reinfection.

Deisenhammer said that the immune response of recoverees who have had a single jab would be even more impressive.

He said these people would have an "absolute, almost one hundred percent certainty" that they will no longer be infected.

"The antibody measurements speak a clear language: you experience an enormous immune reaction if you been revaccinated between six and twelve months after recovery. Vaccinated people simply record an enormous increase in antibodies."

SEE ALSO: ‘Seven percent of Austrians infected with coronavirus’ since pandemic began



The Local 2021/06/20 15:57

Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also